Real world initiation of newly funded empagliflozin and dulaglutide under special authority for patients with type 2 diabetes in New Zealand.
Saved in:
| Title: | Real world initiation of newly funded empagliflozin and dulaglutide under special authority for patients with type 2 diabetes in New Zealand. |
|---|---|
| Authors: | Chepulis L; Waikato Medical Research Centre, University of Waikato, Private Bag 3105, Hamilton, New Zealand. Lynnec@waikato.ac.nz., Rodrigues M; Waikato Medical Research Centre, University of Waikato, Private Bag 3105, Hamilton, New Zealand., Gan H; School of Computing and Mathematical Scienes, University of Waikato, Hamilton, New Zealand., Keenan R; Waikato Medical Research Centre, University of Waikato, Private Bag 3105, Hamilton, New Zealand., Kenealy T; Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand., Murphy R; Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.; Health New Zealand / Te Whatu Ora Te Toka Tumai, Auckland, New Zealand., Karu LT; Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand., Scott-Jones J; Midlands Health Network, Hamilton, New Zealand., Clark P; Northcare Medical Centre, Hamilton, New Zealand., Moffitt A; Procare Health Limited, Auckland, New Zealand., Mustafa S; Waikato Medical Research Centre, University of Waikato, Private Bag 3105, Hamilton, New Zealand., Lawrenson R; Waikato Medical Research Centre, University of Waikato, Private Bag 3105, Hamilton, New Zealand., Paul R; Waikato Medical Research Centre, University of Waikato, Private Bag 3105, Hamilton, New Zealand.; Health New Zealand / Te Whatu Ora Waikato, Hamilton, New Zealand. |
| Source: | BMC health services research [BMC Health Serv Res] 2025 Mar 26; Vol. 25 (1), pp. 433. Date of Electronic Publication: 2025 Mar 26. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101088677 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6963 (Electronic) Linking ISSN: 14726963 NLM ISO Abbreviation: BMC Health Serv Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40140836 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Real world initiation of newly funded empagliflozin and dulaglutide under special authority for patients with type 2 diabetes in New Zealand. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Chepulis+L%22">Chepulis L</searchLink>; Waikato Medical Research Centre, University of Waikato, Private Bag 3105, Hamilton, New Zealand. Lynnec@waikato.ac.nz.<br /><searchLink fieldCode="AU" term="%22Rodrigues+M%22">Rodrigues M</searchLink>; Waikato Medical Research Centre, University of Waikato, Private Bag 3105, Hamilton, New Zealand.<br /><searchLink fieldCode="AU" term="%22Gan+H%22">Gan H</searchLink>; School of Computing and Mathematical Scienes, University of Waikato, Hamilton, New Zealand.<br /><searchLink fieldCode="AU" term="%22Keenan+R%22">Keenan R</searchLink>; Waikato Medical Research Centre, University of Waikato, Private Bag 3105, Hamilton, New Zealand.<br /><searchLink fieldCode="AU" term="%22Kenealy+T%22">Kenealy T</searchLink>; Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.<br /><searchLink fieldCode="AU" term="%22Murphy+R%22">Murphy R</searchLink>; Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.; Health New Zealand / Te Whatu Ora Te Toka Tumai, Auckland, New Zealand.<br /><searchLink fieldCode="AU" term="%22Karu+LT%22">Karu LT</searchLink>; Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.<br /><searchLink fieldCode="AU" term="%22Scott-Jones+J%22">Scott-Jones J</searchLink>; Midlands Health Network, Hamilton, New Zealand.<br /><searchLink fieldCode="AU" term="%22Clark+P%22">Clark P</searchLink>; Northcare Medical Centre, Hamilton, New Zealand.<br /><searchLink fieldCode="AU" term="%22Moffitt+A%22">Moffitt A</searchLink>; Procare Health Limited, Auckland, New Zealand.<br /><searchLink fieldCode="AU" term="%22Mustafa+S%22">Mustafa S</searchLink>; Waikato Medical Research Centre, University of Waikato, Private Bag 3105, Hamilton, New Zealand.<br /><searchLink fieldCode="AU" term="%22Lawrenson+R%22">Lawrenson R</searchLink>; Waikato Medical Research Centre, University of Waikato, Private Bag 3105, Hamilton, New Zealand.<br /><searchLink fieldCode="AU" term="%22Paul+R%22">Paul R</searchLink>; Waikato Medical Research Centre, University of Waikato, Private Bag 3105, Hamilton, New Zealand.; Health New Zealand / Te Whatu Ora Waikato, Hamilton, New Zealand. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101088677%22">BMC health services research</searchLink> [BMC Health Serv Res] 2025 Mar 26; Vol. 25 (1), pp. 433. <i>Date of Electronic Publication: </i>2025 Mar 26. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101088677 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1472-6963 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214726963%22">14726963 </searchLink><i>NLM ISO Abbreviation: </i>BMC Health Serv Res <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40140836 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s12913-025-12601-3 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 433 Titles: – TitleFull: Real world initiation of newly funded empagliflozin and dulaglutide under special authority for patients with type 2 diabetes in New Zealand. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Chepulis L – PersonEntity: Name: NameFull: Rodrigues M – PersonEntity: Name: NameFull: Gan H – PersonEntity: Name: NameFull: Keenan R – PersonEntity: Name: NameFull: Kenealy T – PersonEntity: Name: NameFull: Murphy R – PersonEntity: Name: NameFull: Karu LT – PersonEntity: Name: NameFull: Scott-Jones J – PersonEntity: Name: NameFull: Clark P – PersonEntity: Name: NameFull: Moffitt A – PersonEntity: Name: NameFull: Mustafa S – PersonEntity: Name: NameFull: Lawrenson R – PersonEntity: Name: NameFull: Paul R IsPartOfRelationships: – BibEntity: Dates: – D: 26 M: 03 Text: 2025 Mar 26 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1472-6963 Numbering: – Type: volume Value: 25 – Type: issue Value: 1 Titles: – TitleFull: BMC health services research Type: main |
| ResultId | 1 |